1Herbst RS, Yano S, Kuniyasu H, et al. Differential expression of E - cad- herin and type 1V conagenase genes predicts outcome in patients with stage I non - small cell lung carcinoma. Clin Cancer Res , 2000,6: 790 - 797.
2Skobe M, Hmnberg LM, Hawighorst T, et al. Induction of tumor lymphangio- genesis by VEGF - C promotes breast cancer metastasis. Nature Medicine, 2001,7:192 - 198.
3Tang RF, Itakura J, Akiawa T, el al. Overexpression of lymphangiogenic growh factor VEGF- C in human pancreatic cancer . Pancreas, 2001,22: 285 - 292.
4Li YS, Kaneko M, Amatyo VJ, et al. Expression of vascular endolhelial growth factor- C and its receptor in invasive micropapillary carcinoma of the breast. Pathol Int, 2006,56(5) :256 - 261.
5Schoppmann SF, Bimer P, Studer P, et al. Lymphatic mierovessel density and lymphovaseular invasion assessed by anti - podoplanin immunestaining in human breat cancer . Anticancer Res, 2001,21 (4A) : 2351 - 2355.
6kdachi Y, Nakamura H, Kitamura Y, et al. Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti - podoplanin or anti - D2 - 40 antibody is correlated with lymphatic invasion or lymph nmte metastases. Pathol Int, 2007,57(4) : 171 - 177.
7Makin T, Jussila L, Veikkola T, et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor - 3 .Nat Med,2001,7: 199 - 255.
8Padera TP, Kadambi A, Tomaso E, et al. Lymphatic metastasis in the ab sence of functional intratumor lymphatic . Science,2002,296(5574) : 1883 - 1886.
9Shida A, Fujioka S, Kobayashi K, et al. Expression of vascular endothelial growth factor (VEGF) - C and - D in gastric carcinoma. Int J Clin Oncol, 2006,11(1):38-43.
2Han FH, Li HM, Zheng DH,et al. The effect of the expression ofvascular endothelial growth factor ( VEGF) -C and VEGF receptor-3on the clinical outcome in patients with gastric carcinoma. Eur JSurg Oncol. 2010,36(12) : 1172-1179.
